Browse Title Index

Issue Title
Vol 11, No 4 (2015): July/August 12-Month safety and effectiveness of once-daily hydrocodone Abstract
Warren Wen, PhD, Louise Taber, MD, Shau Yu Lynch, PhD, Ellie He, PhD, Steven Ripa, MD
Vol 10, No 4 (2014): July/August 2014 INTERNATIONAL CONFERENCE ON OPIOIDS Posters presented June 8-10, 2014 Abstract
JOM Editors
Vol 12, No 6 (2016): November/December 2017 International Conference on Opioids Announcement Abstract
2017 ICOO Conference Committee
Vol 13, No 1 (2017): January/February 2017 International Conference on Opioids Brochure and Schedule Details
Conference Committee
Vol 12, No 6 (2016): November/December A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipation Abstract
Lynn Webster, MD, Raj Tummala, MD, MBA, MS, Ulysses Diva, PhD, Jaakko Lappalainen, MD, PhD
Vol 14, No 3 (2018): May/June A case for opioid education and training for medical students, residents, and allied health staff: response to “educational intervention for physicians to address the risk of opioid abuse” Abstract
Anees Bahji, BScH, MD, Daenis Camiré, BScN, RN, MD
Vol 15, No 3 (2019): May/June A case report of sweating caused by hydromorphone Abstract
Lauren E. Bode, PharmD, BCPS
Vol 10, No 3 (2014): May/June A chart review based comparative study of retention rates for two dispensing regimens for buprenorphine for subjects with opioid dependence at a tertiary care substance use disorder treatment center Abstract
Yatan Pal Singh Balhara, MD, DNB, MNAMS
Vol 14, No 6 (2018): November/December A claims analysis of the utilization of tramadol for acute pain in patients prescribed buprenorphine/naloxone for opioid use disorder Abstract
Kellye Donovan, PharmD, PhD, MHA, Stephen Kogut, PhD, MBA, Ashley Buchanan, DrPH, MS, Xuerong Wen, PhD, MPH, Robert Crausman, MD, MMS
Vol 8, No 2 (2012): March/April A comparative study on the effects of intrathecal morphine added to levobupivacaine for spinal anesthesia Abstract
Hakki Unlugenc, MD, Murat Gunduz, MD, Baris Guzel, MD, Geylan Isik, MD
Vol 7, No 5 (2011): September/October A comparison of methods of administering the Opioid Risk Tool Abstract
Ted Jones, PhD, Steven D. Passik, PhD
Vol 1, No 5 (2005): November/December A comparison of oral and implant naltrexone outcomes at 12 months Abstract   PDF
Ross Colquhoun, BPsych(Hons), Donald Y-K. Tan, MBBS, Samantha Hull, BPsych(Hons)
Vol 3, No 2 (2007): March/April A comparison of oral midazolam, oral tramadol, and intranasal sufentanil premedication in pediatric patients Abstract   PDF
Fatma Bayrak, MD, Isil Gunday, MD, Dilek Memis, MD, Alparslan Turan, MD
Vol 2, No 2 (2006): March/April A comparison of patient-controlled epidural pethidine vs. nurse-administered epidural pethidine for analgesia after caesarean section Abstract   PDF
Yvonne Lim, MMed, Sally Wilson, Steven Katz, MD
Vol 1, No 1 (2005): March/April A comparison of rapid (opioid) detoxification with clonidine-assisted detoxification for heroin-dependent persons Abstract   PDF
Diane E. Arnold-Reed, PhD, Gary K. Hulse, PhD
Vol 13, No 2 (2017): March/April A comprehensive clinical review of opioid-induced allodynia: Discussion of the current evidence and clinical implications Abstract
Corey J. Hayes, PharmD, MPH, Jacob T. Painter, PharmD, MBA, PhD
Vol 2, No 2 (2006): March/April A descriptive case series: Oral transmucosal fentanyl use in patients with noncancerous pain Abstract   PDF
Anthony H. Guarino, MD, Jennifer Myers, RN, MSN, ANP, Martha E. Cornell, RN, BSN
Vol 7, No 1 (2011): January/February A double-blind, double-dummy, randomized controlled study of memantine versus buprenorphine in naloxone-precipitated acute withdrawal in heroin addicts Abstract
Kushal Jain, MD, Raka Jain, PhD, FRSC Chem, Anju Dhawan, MD
Vol 6, No 5 (2010): September/October A double-blind, placebo-controlled study of dual-opioid treatment with the combination of morphine plus oxycodone in patients with acute postoperative pain Abstract
Lynn Webster, MD, Patricia Richards, MD, PhD, Warren Stern, PhD, Robin Kelen, RN, BA, CNN
Vol 15, No 3 (2019): May/June A longitudinal analysis of temporal and spatial incidence of neonatal abstinence syndrome in Ontario: 2003-2016 Abstract
Emily Dawson, MPH, Julia Lew, MD Candidate, Dane Mauer-Vakil, BKin, Adam Van Dijk, MSc, Paul Belanger, PhD, Kieran M. Moore, MD
Vol 12, No 6 (2016): November/December A more balanced approach to opioid use and management is also needed in end-of-life care Abstract
Sydney Morss Dy, MD, MSc, Cynda Hylton Rushton, PhD, RN, FAAN
Vol 10, No 6 (2014): November/December A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain Abstract
Samir Arora, MD, Beatrice Setnik, PhD, Michael Drass, MD, John D. Hudson, MD, Ray Clemmer, MS, Paul Meisner, PharmD, Glenn C. Pixton, MS, Veeraindar Goli, MD, Kenneth W. Sommerville, MD
Vol 10, No 5 (2014): September/October A multifactorial intervention for hospital opioid management Abstract
Mehmet Akce, MD, Anupam Suneja, MD, Cheryl Genord, RPh, Bonita Singal, MD, PhD, John A. Hopper, MD
Vol 14, No 6 (2018): November/December A nasal abuse potential randomized clinical trial of REMOXY® ER, a high-viscosity extended-release oxycodone formulation Abstract
Nadav Friedmann, PhD, MD, Michael R. Marsman, PharmD, Annelies W. de Kater, PhD, Lindsay H. Burns, PhD, Lynn R. Webster, MD
Vol 3, No 4 (2007): July/August A new type of harm reduction: Creating an arteriovenous fistula for a compulsively injecting opiate user Abstract
Colin Brewer, MB, Mohammed Sobeh, FRCS
1 - 25 of 786 Items 1 2 3 4 5 6 7 8 9 10 > >> 
This site uses cookies to maintain session information critical to the user's experience and environment on this system. Click "Accept Cookies" to continue.
For more details please visit our privacy statement at: Privacy & GDPR